Evidence map›Paper›PMID 39564735›Full record

ArticleHistopathology2025

Recurrent GRHL fusions in a subset of sebaceoma: microscopic and molecular characterisation of eight cases.

Mélanie Legrand, Baptiste Louveau, Nicolas Macagno, Maxence Mancini, Dmitry V Kazakov, Daniel Pissaloux, Franck Tirode, Anne Tallet, Samia Mourah, Quentin Lepiller and 10 more

Abstract read
In one paragraph

Article in Histopathology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. The acinar variant of poroma: a series of 3 cases with YAP1::NR4A3 fusion.Virchows Archiv : an international journal of pathology · 2026
    Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

20 authors.

Mélanie LegrandDepartment of Pathology, Université de Tours, Centre Hospitalier Universitaire de Tours, Tours, France.ORCID https://orcid.org/0009-0000-3949-3728
Baptiste LouveauDepartment of Tumour Genomics and Pharmacology, Hôpital Saint Louis, Université Paris Cité, Human Immunology Pathophysiology and Immunotherapy (HIPI), Paris, France.ORCID https://orcid.org/0000-0001-5411-3893
Nicolas MacagnoCARADERM Network, Fédération de Recherche Clinique, Lille, France.ORCID https://orcid.org/0000-0002-9882-2162
Maxence ManciniDepartment of Tumour Genomics and Pharmacology, Hôpital Saint Louis, Université Paris Cité, Human Immunology Pathophysiology and Immunotherapy (HIPI), Paris, France.ORCID https://orcid.org/0009-0006-2110-0723
Dmitry V KazakovIDP Dermatohistopathologie Institut, Pathologie Institut Enge, Zurich, Switzerland.ORCID https://orcid.org/0000-0003-0560-325X
Daniel PissalouxDepartment of Biopathology, Center Léon Bérard, Lyon, France.ORCID https://orcid.org/0000-0003-1118-950X
Franck TirodeDepartment of Biopathology, Center Léon Bérard, Lyon, France.ORCID https://orcid.org/0000-0003-4731-7817
Anne TalletPlatform of Somatic Tumour Molecular Genetics, Université de Tours, Centre Hospitalier Universitaire de Tours, Tours, France.ORCID https://orcid.org/0000-0002-2601-2443
Samia MourahDepartment of Tumour Genomics and Pharmacology, Hôpital Saint Louis, Université Paris Cité, Human Immunology Pathophysiology and Immunotherapy (HIPI), Paris, France.ORCID https://orcid.org/0000-0002-9283-1068
Quentin LepillerFrench National Papillomavirus Reference Center, CHU de Besançon, Université de Franche-Comté, Besançon, France.ORCID https://orcid.org/0000-0003-2892-4216
Arnaud de la FouchardièreDepartment of Biopathology, Center Léon Bérard, Lyon, France.ORCID https://orcid.org/0000-0003-2251-8241
Pierre SohierCARADERM Network, Fédération de Recherche Clinique, Lille, France.ORCID https://orcid.org/0000-0002-2341-6848
Eric FrouinCARADERM Network, Fédération de Recherche Clinique, Lille, France.ORCID https://orcid.org/0000-0002-8432-3194
Andreas von DeimlingDepartment of Neuropathology, Institute of Pathology, Ruprecht-Karls-University, Heidelberg, Germany.ORCID https://orcid.org/0000-0002-5863-540X
Keisuke GotoDepartment of Pathology, Tokyo Metropolitan Cancer and Infectious Disease Center, Komagome Hospital, Tokyo, Japan.ORCID https://orcid.org/0000-0002-4165-1809
Bernard CribierCARADERM Network, Fédération de Recherche Clinique, Lille, France.ORCID https://orcid.org/0000-0002-6306-770X
Eduardo CalonjeDepartment of Dermatopathology, St John's Institute of Dermatology, St Thomas' Hospital, London, UK.ORCID https://orcid.org/0000-0001-7475-6423
Saleem TaibjeeDermatology Department, Dorset County Hospital NHS Foundation Trust, Dorchester, UK.ORCID https://orcid.org/0000-0003-2433-5481
Maxime BattistellaCARADERM Network, Fédération de Recherche Clinique, Lille, France.ORCID https://orcid.org/0000-0002-7053-7431
Thibault KervarrecDepartment of Pathology, Université de Tours, Centre Hospitalier Universitaire de Tours, Tours, France.ORCID https://orcid.org/0000-0002-2201-6914

Funding

illumina grant
6 · The paper itself

Abstract

aimsSebaceous neoplasms constitute a group of adnexal tumours, including sebaceous adenoma, sebaceoma and sebaceous carcinoma. Although mismatch repair deficiency may be observed, the nature of the genetic alterations contributing to the development of most of these tumours is still unknown. In the present study, we describe the clinical, microscopic, and molecular features of eight sebaceomas with GRHL gene rearrangement. METHODS AND

resultsAmong these sebaceomas, four occurred in women and four in men; the median age was 63 years (range = 29-89). The tumours were located in the head and neck area in all cases. Microscopic examination revealed a well-demarcated lesion located in the dermis with focal extension into the subcutaneous tissue (three cases). The neoplasms displayed macronodular (eight cases), cribriform (seven cases) and organoid (six cases) growth patterns, occurring in combination. The tumours were mainly composed of immature basophilic cells associated with scattered mature sebocytes. Numerous small infundibular cysts were present in seven cases. Mitotic activity was low (none/one to four mitoses/mm

conclusionsIn conclusion, we report recurrent fusions of the GRHL genes in a distinctive subset of sebaceomas harbouring infundibulocystic differentiation, a frequent organoid growth pattern and lack of mismatch repair deficiency.

Indexed as

AdenomaDNA-Binding ProteinsSebaceous Gland NeoplasmsTranscription FactorsAdultAgedAged, 80 and overFemaleHumansMaleMiddle AgedDNA-Binding ProteinsGRHL2 protein, humanTranscription Factors

Identifiers

PMID39564735
PMCPMC11791738

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.